VTCN1_RAT
ID VTCN1_RAT Reviewed; 282 AA.
AC Q501W4;
DT 10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT 07-JUN-2005, sequence version 1.
DT 03-AUG-2022, entry version 102.
DE RecName: Full=V-set domain-containing T-cell activation inhibitor 1;
DE Flags: Precursor;
GN Name=Vtcn1 {ECO:0000312|EMBL:AAH95842.1};
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Rattus.
OX NCBI_TaxID=10116;
RN [1] {ECO:0000312|EMBL:AAH95842.1}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Thymus {ECO:0000312|EMBL:AAH95842.1};
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
CC -!- FUNCTION: Negatively regulates T-cell-mediated immune response by
CC inhibiting T-cell activation, proliferation, cytokine production and
CC development of cytotoxicity. When expressed on the cell surface of
CC tumor macrophages, plays an important role, together with regulatory T-
CC cells (Treg), in the suppression of tumor-associated antigen-specific
CC T-cell immunity. Involved in promoting epithelial cell transformation
CC (By similarity). {ECO:0000250|UniProtKB:Q7TSP5,
CC ECO:0000250|UniProtKB:Q7Z7D3}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q7TSP5};
CC Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:Q7TSP5}. Note=Expressed
CC at the cell surface. A soluble form has also been detected (By
CC similarity). {ECO:0000250|UniProtKB:Q7TSP5}.
CC -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q7Z7D3}.
CC -!- SIMILARITY: Belongs to the immunoglobulin superfamily. BTN/MOG family.
CC {ECO:0000250|UniProtKB:Q5ZPR3}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC095842; AAH95842.1; -; mRNA.
DR RefSeq; NP_001019415.1; NM_001024244.1.
DR AlphaFoldDB; Q501W4; -.
DR SMR; Q501W4; -.
DR STRING; 10116.ENSRNOP00000020566; -.
DR GlyGen; Q501W4; 1 site.
DR PaxDb; Q501W4; -.
DR Ensembl; ENSRNOT00000020566; ENSRNOP00000020566; ENSRNOG00000015279.
DR GeneID; 295322; -.
DR KEGG; rno:295322; -.
DR UCSC; RGD:1311204; rat.
DR CTD; 79679; -.
DR RGD; 1311204; Vtcn1.
DR eggNOG; ENOG502S286; Eukaryota.
DR GeneTree; ENSGT00940000157300; -.
DR HOGENOM; CLU_013137_8_6_1; -.
DR InParanoid; Q501W4; -.
DR OMA; DQNEMFR; -.
DR OrthoDB; 1040668at2759; -.
DR PhylomeDB; Q501W4; -.
DR TreeFam; TF331083; -.
DR PRO; PR:Q501W4; -.
DR Proteomes; UP000002494; Chromosome 2.
DR Bgee; ENSRNOG00000015279; Expressed in ovary and 9 other tissues.
DR Genevisible; Q501W4; RN.
DR GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR GO; GO:0050868; P:negative regulation of T cell activation; ISO:RGD.
DR GO; GO:0042130; P:negative regulation of T cell proliferation; ISO:RGD.
DR GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR GO; GO:0042102; P:positive regulation of T cell proliferation; ISO:RGD.
DR GO; GO:0001817; P:regulation of cytokine production; IBA:GO_Central.
DR GO; GO:0001562; P:response to protozoan; ISO:RGD.
DR GO; GO:0050852; P:T cell receptor signaling pathway; IBA:GO_Central.
DR Gene3D; 2.60.40.10; -; 2.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR013106; Ig_V-set.
DR Pfam; PF07686; V-set; 1.
DR SMART; SM00409; IG; 1.
DR SUPFAM; SSF48726; SSF48726; 2.
DR PROSITE; PS50835; IG_LIKE; 2.
PE 2: Evidence at transcript level;
KW Adaptive immunity; Cell membrane; Disulfide bond; Glycoprotein; GPI-anchor;
KW Immunity; Immunoglobulin domain; Lipoprotein; Membrane; Reference proteome;
KW Repeat; Signal.
FT SIGNAL 1..24
FT /evidence="ECO:0000255"
FT CHAIN 25..257
FT /note="V-set domain-containing T-cell activation inhibitor
FT 1"
FT /evidence="ECO:0000255"
FT /id="PRO_0000339240"
FT PROPEP 258..282
FT /note="Removed in mature form"
FT /evidence="ECO:0000255"
FT /id="PRO_0000339241"
FT DOMAIN 35..144
FT /note="Ig-like V-type 1"
FT /evidence="ECO:0000255"
FT DOMAIN 153..241
FT /note="Ig-like V-type 2"
FT /evidence="ECO:0000255"
FT LIPID 257
FT /note="GPI-anchor amidated glycine"
FT /evidence="ECO:0000255"
FT CARBOHYD 216
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 56..130
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT DISULFID 168..225
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ SEQUENCE 282 AA; 30664 MW; A487A8DABF27E41C CRC64;
MASLGQIIFW SIINVIIILA GAIVLIIGFG ISGKHFITVT TFTSAGNIGE DGTLSCTFEP
DIKLNGIVIQ WLKEGIKGLV HEFKEGKDDL SQQHEMFRGR TAVFADQVVV GNASLRLKNV
QLTDAGTYTC YIHTSKGKGN ANLEYKTGAF SMPEINVDYN ASSESLRCEA PRWFPQPTVA
WASQVDQGAN FSEVSNTSFE LNSENVTMKV VSVLYNVTIN NTYSCMIEND IAKATGDIKV
TDSEVKRRSQ LELLNSGPSP CVSSVSAAGW ALLSLSCCLM LR